Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma

Long-term survival of participants in the PASART-1 and PASART-2 trials of neo-adjuvant pazopanib and radiotherapy in soft tissue sarcoma

Objective: This study aims to assess the long-term safety and efficacy of adding pazopanib to neo-adjuvant radiotherapy followed by surgery in patients with high-risk non-metastatic soft tissue sarcoma of the trunk and extremities treated in the PASART-1 and PASART-2 trials, as well as to compare th...

Full description

Bibliographic Details
Main Authors: Bauke H.G. van Riet, Milan van Meekeren, Marta Fiocco, Aisha Miah, Ilse de Pree, Lisette M. Wiltink, Astrid Scholten, Lotte Heimans, Judith V.M.G. Bovée, Hans Gelderblom, Neeltje Steeghs, Rick L. Haas
Format: Article
Language:English
Published: Medical Journals Sweden 2025-01-01
Series:Acta Oncologica
Subjects:
Pre-operative
chemoradiotherapy
soft-tissue sarcoma
pazopanib
Online Access:https://medicaljournalssweden.se/actaoncologica/article/view/42333

Internet

https://medicaljournalssweden.se/actaoncologica/article/view/42333

Similar Items